Ladenburg Thalmann Financial Services’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$20K	Sell	5,825 -9,900	-63%	-$23.6K	﹤0.01%	4160
2019 Q3	$34K	Hold	15,725	–	–	﹤0.01%	3703
2019 Q2	$42K	Hold	15,725	–	–	﹤0.01%	3586
2019 Q1	$75K	Sell	15,725 -1,000	-6%	-$2.62K	﹤0.01%	3106
2018 Q4	$40K	Buy	16,725 +1,000	+6%	+$3.27K	﹤0.01%	3421
2018 Q3	$69K	Buy	15,725 +13,650	+658%	+$75.7K	﹤0.01%	3115
2018 Q2	$11K	Hold	2,075	–	–	﹤0.01%	4216
2018 Q1	$11K	Buy	+2,075	New	+$14.8K	﹤0.01%	4216
2015 Q3	–	Sell	-500	Closed	-$9K	–	4775
2015 Q2	$9K	Hold	500	–	–	﹤0.01%	3775
2015 Q1	$6K	Hold	500	–	–	﹤0.01%	3918
2014 Q4	$5K	Buy	+500	New	+$2.53K	﹤0.01%	3762

Other funds holding SRNE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ladenburg Thalmann Financial Services's SRNE Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Sorrento Therapeutics, Inc. (SRNE) stake by 63% in Q4 2019, selling an estimated $23.6K and leaving 5,825 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #4160.

Ladenburg Thalmann Financial Services first reported a position in SRNE in Q4 2014 and has held it in 11 quarters since. The position peaked at $75K in Q1 2019. 88 funds tracked by Wall St. Rank hold SRNE as of Q4 2019.

Ladenburg Thalmann Financial Services held 5,825 shares of Sorrento Therapeutics, Inc. worth $20K as of Q4 2019.
Ladenburg Thalmann Financial Services sold 9,900 Sorrento Therapeutics, Inc. shares in Q4 2019, an estimated $23.6K.
Sorrento Therapeutics, Inc. made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4160 holding.
Ladenburg Thalmann Financial Services first reported a position in Sorrento Therapeutics, Inc. in Q4 2014 and has held it in 11 quarters since.
Ladenburg Thalmann Financial Services's Sorrento Therapeutics, Inc. position peaked at $75K in Q1 2019.
88 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.